Prothena Co. plc (NASDAQ: PRTA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Prothena Co. plc (NASDAQ: PRTA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $84.00 price target on the stock.
Prothena Q3 Earnings Beat Estimates, Pipeline Progress in Focus [Yahoo! Finance]
Prothena (PRTA) Reports Q3 Loss, Misses Revenue Estimates [Yahoo! Finance]
Prothena Reports Third Quarter 2024 Financial Results and Business Highlights [Yahoo! Finance]